Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.1530
H.R.1530: Prescription Drug Competition Act of 2001
About This Bill
- This bill was introduced in the 107th Congress
- This bill is primarily about law
- Introduced April 4, 2001
- Latest Major Action Oct. 11, 2001
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
5 (All Democrats)
Bill Summary
Prescription Drug Competition Act of 2001 - Requires brand name drug companies and generic drug applicants to file with the Federal Trade Commission and the Secretary of Health and Human Services specified information regarding any agreement regarding the sale or manufacture of a generic drug which the Secretary has determined is the therapeutic equivalent of the brand name drug or for which the applicant seeks a determination of therapeutic...
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
|
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
|
|
Referred to House Energy and Commerce
|
|
|
Referred to House Judiciary
|
|
|
Referred to the Subcommittee on Health.
|
|
|
Sponsor introductory remarks on measure.
|
|
| April 4, 2001 |
Introduced in the House by Henry A. Waxman (D-Calif.) |